Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Randomized Study to Compare the Safety and Efficacy of Low-dose Versus Standard Dose Lopinavir/Ritonavir Containing HAART Regimen in Virological Suppressed HIV-infected Thai Children

NCT01307124 is registered in ClinicalTrials.gov with The HIV Netherlands Australia Thailand Research Collaboration as lead sponsor.

NCT NCT01307124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01307124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Randomized Study to Compare the Safety and Efficacy of Low-dose Versus Standard Dose Lopinavir/Ritonavir Containing HAART Regimen in Virological Suppressed HIV-infected Thai Children
Lead sponsor
The HIV Netherlands Australia Thailand Research Collaboration
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2011
Completion date
April 30, 2013
Enrollment
199 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-infected children